Actigraphic Measurement of a Neurosurgical Procedure
Not Applicable
Completed
- Conditions
- Sleep DisordersCircadian RhythmPainRehabilitationMood Lability
- Interventions
- Procedure: Re-section of a large left anterior cranial fossa meningioma
- Registration Number
- NCT00945230
- Lead Sponsor
- Child Psychopharmacology Institute
- Brief Summary
The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.
- Detailed Description
Actigraphic measurements, repeated verbal fluency and multi-symptom operationally defined observations will be recorded for an 11 to 12 day baseline period and continued following neurosurgical tumor resection until a repeat MRI is completed three months after the procedure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1
Inclusion Criteria
- Diagnosis of incidental meningioma
- Single subject preparing to receive neurosurgical intervention
Exclusion Criteria
- Inability to wear actigraphy device
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Actigraphic Neurosurgical Outcomes Re-section of a large left anterior cranial fossa meningioma Actigraphic measurements that will be obtained by attaching the actigraphic watch device to the individual's non-dominant wrist and operationally defined repeated observational measurements. All measurements will continue through a baseline period and continue through the identified post surgical period. Actigraphic measurements will occur every 30 seconds with brief periods of non-measurement during the actual neurosurgical procedure and periods when the actigraphic device has reached storage capacity (approximately every 22 days) when data is retrieved and the device prepared resume measurements.
- Primary Outcome Measures
Name Time Method Pre and Post Actigraphic and Systematic Observation Scale measurements March 15, 2009-June 20, 2009
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Child Psychopharmacology Institute
🇺🇸Fargo, North Dakota, United States